Galectin-3 suppresses mucosal inflammation and reduces disease severity in experimental colitis

Journal of Molecular Medicine

Volumn 94, Issue 5, 2016, Pages 545-556

  Tsai, Hwei Fang ^a,b   Wu, Chien Sheng ^c   Chen, Yi Lin ^d   Liao, Hsiu Jung ^d   Chyuan, I Tsu ^e   Hsu, Ping Ning ^d,f  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e CATHAY GENERAL HOSPITAL   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Galectin 3; Inflammatory bowel disease; Regulatory T cells

Indexed keywords

DEXTRAN SULFATE; GALECTIN 3; INDUCIBLE T CELL COSTIMULATOR; PROGRAMMED DEATH 1 LIGAND 1; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR FOXP3; BIOLOGICAL MARKER; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; ICOS PROTEIN, MOUSE; PROGRAMMED DEATH 1 RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL TRANSFER; CONTROLLED STUDY; DISEASE SEVERITY; EX VIVO STUDY; EXPERIMENTAL COLITIS; HUMAN; HUMAN CELL; IMMUNOMODULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; WEIGHT REDUCTION; ANIMAL; COLITIS; DISEASE MODEL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; KNOCKOUT MOUSE; LYMPHOCYTE DEPLETION; METABOLISM; PATHOLOGY; PHENOTYPE; SEVERITY OF ILLNESS INDEX; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; BIOMARKERS; COLITIS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; GALECTIN 3; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INTESTINAL MUCOSA; LYMPHOCYTE DEPLETION; MICE; MICE, KNOCKOUT; PHENOTYPE; PROGRAMMED CELL DEATH 1 RECEPTOR; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84948981862     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-015-1368-x     Document Type: Article

References (47)

1. Rabinovich GA, Toscano MA (2009) Turning ‘sweet’ on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 9:338–352
2. Chen HY, Fermin A, Vardhana S, Weng IC, Lo KF, Chang EY, Maverakis E, Yang RY, Hsu DK, Dustin ML et al (2009) Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse. Proc Natl Acad Sci U S A 106:14496–14501
3. Fukumori T, Takenaka Y, Yoshii T, Kim HR, Hogan V, Inohara H, Kagawa S, Raz A (2003) CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res 63:8302–8311
4. Stillman BN, Hsu DK, Pang M, Brewer CF, Johnson P, Liu FT, Baum LG (2006) Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol 176:778–789
5. Jiang HR, Al Rasebi Z, Mensah-Brown E, Shahin A, Xu D, Goodyear CS, Fukada SY, Liu FT, Liew FY, Lukic ML (2009) Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis. J Immunol 182:1167–1173
6. Forsman H, Islander U, Andreasson E, Andersson A, Onnheim K, Karlstrom A, Savman K, Magnusson M, Brown KL, Karlsson A (2011) Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis. Arthritis Rheum 63:445–454
7. Saegusa J, Hsu DK, Chen HY, Yu L, Fermin A, Fung MA, Liu FT (2009) Galectin-3 is critical for the development of the allergic inflammatory response in a mouse model of atopic dermatitis. Am J Pathol 174:922–931
8. Fermin Lee A, Chen HY, Wan L, Wu SY, Yu JS, Huang AC, Miaw SC, Hsu DK, Wu-Hsieh BA, Liu FT (2013) Galectin-3 modulates Th17 responses by regulating dendritic cell cytokines. Am J Pathol 183:1209–1222
9. Kamada N, Seo SU, Chen GY, Nunez G (2013) Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 13:321–335
10. Peterson LW, Artis D (2014) Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 14:141–153
11. Frol'ova L, Smetana K Jr, Borovska D, Kitanovicova A, Klimesova K, Janatkova I, Malickova K, Lukas M, Drastich P, Benes Z et al (2009) Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD? Inflamm Res 58:503–512
12. Jensen-Jarolim E, Gscheidlinger R, Oberhuber G, Neuchrist C, Lucas T, Bises G, Radauer C, Willheim M, Scheiner O, Liu FT et al (2002) The constitutive expression of galectin-3 is downregulated in the intestinal epithelia of Crohn's disease patients, and tumour necrosis factor alpha decreases the level of galectin-3-specific mRNA in HCT-8 cells. Eur J Gastroenterol Hepatol 14:145–152
13. Muller S, Schaffer T, Flogerzi B, Fleetwood A, Weimann R, Schoepfer AM, Seibold F (2006) Galectin-3 modulates T cell activity and is reduced in the inflamed intestinal epithelium in IBD. Inflamm Bowel Dis 12:588–597
14. Bregenholt S, Claesson MH (1998) Splenic T helper cell type 1 cytokine profile and extramedullary haematopoiesis in severe combined immunodeficient (scid) mice with inflammatory bowel disease (IBD). Clin Exp Immunol 111:166–172
15. Hundorfean G, Neurath MF, Mudter J (2012) Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease. Inflamm Bowel Dis 18:180–186
16. Iijima H, Takahashi I, Kishi D, Kim JK, Kawano S, Hori M, Kiyono H (1999) Alteration of interleukin 4 production results in the inhibition of T helper type 2 cell-dominated inflammatory bowel disease in T cell receptor alpha chain-deficient mice. J Exp Med 190:607–615
17. Monteleone I, Sarra M, Pallone F, Monteleone G (2012) Th17-related cytokines in inflammatory bowel diseases: friends or foes? Curr Mol Med 12:592–597
18. Tanner SM, Staley EM, Lorenz RG (2013) Altered generation of induced regulatory T cells in the FVB.mdr1a-/- mouse model of colitis. Mucosal Immunol 6:309–323
19. Okamura M, Yoh K, Ojima M, Morito N, Takahashi S (2014) Overexpression of GATA-3 in T cells accelerates dextran sulfate sodium-induced colitis. Exp Anim 63:133–140
20. Sujino T, Kanai T, Ono Y, Mikami Y, Hayashi A, Doi T, Matsuoka K, Hisamatsu T, Takaishi H, Ogata H et al (2011) Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells. Gastroenterology 141:1014–1023
21. Lindebo Holm T, Poulsen SS, Markholst H, Reedtz-Runge S (2012) Pharmacological evaluation of the SCID T cell transfer model of colitis: as a model of Crohn’s disease. Int J Inflam 2012:412178
22. Rose WA 2nd, Sakamoto K, Leifer CA (2012) Multifunctional role of dextran sulfate sodium for in vivo modeling of intestinal diseases. BMC Immunol 13:41
23. Yan Y, Kolachala V, Dalmasso G, Nguyen H, Laroui H, Sitaraman SV, Merlin D (2009) Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One 4, e6073
24. Hsu DK, Yang RY, Pan Z, Yu L, Salomon DR, Fung-Leung WP, Liu FT (2000) Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am J Pathol 156:1073–1083
25. Yang RY, Hsu DK, Liu FT (1996) Expression of galectin-3 modulates T-cell growth and apoptosis. Proc Natl Acad Sci U S A 93:6737–6742
26. Robertson MW, Albrandt K, Keller D, Liu FT (1990) Human IgE-binding protein: a soluble lectin exhibiting a highly conserved interspecies sequence and differential recognition of IgE glycoforms. Biochemistry 29:8093–8100
27. Hsu DK, Zuberi RI, Liu FT (1992) Biochemical and biophysical characterization of human recombinant IgE-binding protein, an S-type animal lectin. J Biol Chem 267:14167–14174
28. Schepp-Berglind J, Atkinson C, Elvington M, Qiao F, Mannon P, Tomlinson S (2012) Complement-dependent injury and protection in a murine model of acute dextran sulfate sodium-induced colitis. J Immunol 188:6309–6318
29. Maloy KJ (2007) Induction and regulation of inflammatory bowel disease in immunodeficient mice by distinct CD4+ T-cell subsets. Methods Mol Biol 380:327–335
30. Nakanishi Y, Tsuneyama K, Nomoto K, Fujimoto M, Salunga TL, Nakajima T, Miwa S, Murai Y, Hayashi S, Kato I et al (2008) Nonalcoholic steatohepatitis and hepatocellular carcinoma in galectin-3 knockout mice. Hepatol Res 38:1241–1251
31. Nomoto K, Tsuneyama K, Abdel Aziz HO, Takahashi H, Murai Y, Cui ZG, Fujimoto M, Kato I, Hiraga K, Hsu DK et al (2006) Disrupted galectin-3 causes non-alcoholic fatty liver disease in male mice. J Pathol 210:469–477
32. Pugliese G, Pricci F, Iacobini C, Leto G, Amadio L, Barsotti P, Frigeri L, Hsu DK, Vlassara H, Liu FT et al (2001) Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout mice. FASEB J 15:2471–2479
33. Strauch UG, Obermeier F, Grunwald N, Gurster S, Dunger N, Schultz M, Griese DP, Mahler M, Scholmerich J, Rath HC (2005) Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis. Gut 54:1546–1552
34. Elson CO, Cong Y, Iqbal N, Weaver CT (2001) Immuno-bacterial homeostasis in the gut: new insights into an old enigma. Semin Immunol 13:187–194
35. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB (1998) Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66(66):5224–5231
36. Kohatsu L, Hsu DK, Jegalian AG, Liu FT, Baum LG (2006) Galectin-3 induces death of Candida species expressing specific beta-1,2-linked mannans. J Immunol 177:4718–4726
37. Quattroni P, Li Y, Lucchesi D, Lucas S, Hood DW, Herrmann M, Gabius HJ, Tang CM, Exley RM (2012) Galectin-3 binds Neisseria meningitidis and increases interaction with phagocytic cells. Cell Microbiol 14:1657–1675
38. Sano H, Hsu DK, Apgar JR, Yu L, Sharma BB, Kuwabara I, Izui S, Liu FT (2003) Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest 112:389–397
39. Sato S, St-Pierre C, Bhaumik P, Nieminen J (2009) Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev 230:172–187
40. Stowell SR, Arthur CM, McBride R, Berger O, Razi N, Heimburg-Molinaro J, Rodrigues LC, Gourdine JP, Noll AJ, von Gunten S et al (2014) Microbial glycan microarrays define key features of host-microbial interactions. Nat Chem Biol 10:470–476
41. Wu C, Thalhamer T, Franca RF, Xiao S, Wang C, Hotta C, Zhu C, Hirashima M, Anderson AC, Kuchroo VK (2014) Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells. Immunity 41:270–282
42. Boehm F, Martin M, Kesselring R, Schiechl G, Geissler EK, Schlitt HJ, Fichtner-Feigl S (2012) Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation. BMC Gastroenterol 12:97
43. Fantini MC, Becker C, Tubbe I, Nikolaev A, Lehr HA, Galle P, Neurath MF (2006) Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis. Gut 55:671–680
44. Himmel ME, Yao Y, Orban PC, Steiner TS, Levings MK (2012) Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers. Immunology 136:115–122
45. Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, Qin FX, Gilliet M, Liu YJ (2008) Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28:870–880
46. Garin MI, Chu CC, Golshayan D, Cernuda-Morollon E, Wait R, Lechler RI (2007) Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood 109:2058–2065
47. Seki M, Oomizu S, Sakata KM, Sakata A, Arikawa T, Watanabe K, Ito K, Takeshita K, Niki T, Saita N et al (2008) Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127:78–88